Paolo Spagnolo
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Articles (16)
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Idiopathic pulmonary fibrosis (IPF), the most common and severe of the idiopathic interstitial pneumonias, is a chronic and relentlessly progressive disease, which occurs mostly in middle-aged and elderly males. Although IPF is by definition “idiopathic”, multiple factors have been reported to increase disease risk, aging being the most prominent one. Several occupational and environmental exposures, including metal dust, wood dust and air pollution, as well as various lifestyle variables, including smoking and diet, have also been associated with an increased risk of IPF, probably through interaction with genetic factors. Many of the predisposing factors appear to act also as trigger for acute exacerbations of the disease, which herald a poor prognosis. The more recent literature on inhalation injuries has focused on the first responders in the World Trade Center attacks and military exposure. In this review, we present an overview of the environmental and occupational causes of IPF and its pathogenesis. While our list is not comprehensive, we have selected specific exposures to highlight based on their overall disease burden.
Year:
2023
Sarcoidosis is a multisystemic disease of unknown etiology characterized by the formation of granulomas in various organs, especially lung and mediastinal hilar lymph nodes. The clinical course and manifestations are unpredictable: spontaneous remission can occur in approximately two thirds of patients; up to 20% of patients have chronic course of the lung disease (called advanced pulmonary sarcoidosis, APS) resulting in progressive loss of lung function, sometimes life-threatening that can lead to respiratory failure and death. The immunopathology mechanism leading from granuloma formation to the fibrosis in APS still remains elusive. Recent studies have provided new insights into the genetic factors and immune components involved in the clinical manifestation of the disease. In this review we aim to summarize the clinical-prognostic characteristics and molecular pathways which are believed to be associated with the development of APS.
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Collaborators (13)
Andrea Ticinesi
Università degli Studi di Pavia
Graziella Turato
University of Padova
Francesco Bonella
-
Erica Bazzan
University of Padova
Luca Vedovelli
University of Padua
Andrea Gramegna
Assistant Professor
University of Milan
Roberto Tonelli
Asssitant Professor
University of Modena and Reggio Emilia
Philip L Molyneaux
Imperial College London
Elisabetta Balestro
-
Jose Maria Marin Trigo
Professor of Medicine
Universidad de Zaragoza
Umberto Semenzato
University of Padua
Matteo Daverio
University of Padova
Marcello Tiseo
University of Parma
Make your next move.
Prepare your application
Review drafts before you send them.